Contraception and reproductive planning during the COVID-19 pandemic

62Citations
Citations of this article
324Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Introduction: The coronavirus disease (COVID-19) is a global health emergency. Major disruption to healthcare services during the current COVID-19 pandemic will last even after its peak. Sexual and reproductive health (SRH), specially contraception, needs to be understood as an essential service. Areas covered: This paper is a narrative review. Data from PubMed/MEDLINE, Scopus, and websites of scientific societies were screened during the months of April and May 2020. It addresses the main aspects related to contraception during the COVID-19 pandemic, with special emphasis on family planning services, extended use of long-acting reversible contraceptive (LARC) methods, drug interactions, and thromboembolism risk. We also specified some issues focused on the Brazilian reality. Expert opinion: Ensuring proper contraception use in the COVID-19 time is very important. We encourage women, healthcare providers, policymakers, and the society to consider SRH services as priority.

Cite

CITATION STYLE

APA

Ferreira-Filho, E. S., de Melo, N. R., Sorpreso, I. C. E., Bahamondes, L., Simões, R. D. S., Soares-Júnior, J. M., & Baracat, E. C. (2020, June 2). Contraception and reproductive planning during the COVID-19 pandemic. Expert Review of Clinical Pharmacology. Taylor and Francis Ltd. https://doi.org/10.1080/17512433.2020.1782738

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free